Dyadic International, Inc. ( DYAI) IAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 December 9, 2025 9:30 AM EST Good day, and welcome to the iAcessAlpha Virtual Best Ideas winter ...
CRISPR, the gene-editing technology which won its creators the 2020 Nobel Prize for Chemistry, is most well-known for its ...
Zacks Investment Research on MSN
CRISPR Therapeutics AG (CRSP) is attracting investor attention: Here is what you should know
CRISPR Therapeutics AG (CRSP) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to ...
This year, gene-editing technology was customized to fix mutations in a single patient’s genes for the first time.
A team of researchers at the Icahn School of Medicine at Mount Sinai has uncovered why children with the same ...
Goldenberries taste like a cross between pineapple and mango, pack the nutritional punch of a superfood, and are increasingly ...
Casgevy, now a "national priority" drug, helped kids with sickle cell and thalassemia, results which may help toward a label ...
Turning off the genetic switch to its respiratory system might finally eliminate the bacteria behind tuberculosis.
Nearly three decades since the remarkable cloning of Dolly the sheep, it has all gone quiet on the human cloning front.
Explore Intellia Therapeutics, Inc.'s outlook after Phase 3 trial concerns. See how FDA decisions may impact CRISPR therapy ...
Los Angeles wildfires, a CRISPR milestone, and a de-extinction controversy are among 2025’s notable events captured in photos ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback